RSM logo
Annals of Clinical Biochemistry

Home Current issue Browse archive Alerts About the journal Feedback
 
Ann Clin Biochem 2008;45:260-265
doi:10.1258/acb.2007.007120
© 2008 Association for Clinical Biochemistry

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cramb, R.
Right arrow Articles by MacKenzie, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Original Articles

Lipid external quality assessment: commutability between external quality assessment and clinical specimens

Robert Cramb1, Jane French2, Michael Mackness3, R Dermot G Neely4, Muriel Caslake5 and Finlay MacKenzie2


1 Department of Clinical Biochemistry, University Hospital Birmingham NHS Foundation Trust, Birmingham B15 2TH, UK; 2 UK NEQAS Wolfson EQA Laboratory, Institute of Research and Development, Birmingham Research Park, Birmingham, West Midlands B15 2SQ, UK; 3 Department of Medicine, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL; UK; 4 Department of Clinical Biochemistry, Newcastle Upon Tyne Hospitals, Newcastle Upon Tyne NE1 4LP, UK; 5 University Department of Vascular Biochemistry, 4th Floor, Queen Elizabeth Building, Glasgow Royal Infirmary, Alexandra Parade, Glasgow, G31 2ER, UK


Corresponding author: Dr Robert Cramb. Email: rob.cramb{at}uhb.nhs.uk


Background: Targets for cholesterol reduction are part of the Quality Outcomes Framework and general practitioners have to meet these targets to fulfil their remuneration package. By contrast, there are no targets for the accuracy of cholesterol or other lipid measurements and no recent surveys on performance of these assays. We have assessed the performance of lipid measurement of the available methods in the UK.

Methods: Serum samples collected from individual donors attending the national blood service were distributed after values were obtained from a secondary reference laboratory. Samples were sent to participant laboratories to assess different methods' analytical performance on single donation specimens, on routine external quality assessment pooled specimens, on specimens subjected to a range of freeze–thaw cycles and on frozen-stored specimens.

Results: Differences in measured cholesterol were found that were method-dependent and related to triglyceride content. HDL-cholesterol (HDL-C) showed significant positive bias in all assays. Individual donor specimens showed no significant changes with differing numbers of freeze–thaw cycles. Pooled serum was stable for up to six months.

Conclusions: Most cholesterol measurements are accurate but some methods are affected by triglyceride interference. HDL-C methods show significant positive bias. Although there are potential matrix effects introduced as a result of specimen preparation, additional work is needed to show if these effects are present in fresh patient samples.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




MDU Exam Doctor